The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Antiviral agents active against influenza A viruses
Open accessAbstract
The recent outbreaks of avian influenza A (H5N1) virus, its expanding geographic distribution and its ability to transfer to humans and cause severe infection have raised serious concerns about the measures available to control an avian or human pandemic of influenza A. In anticipation of such a pandemic, several preventive and therapeutic strategies have been proposed, including the stockpiling of antiviral drugs, in particular the neuraminidase inhibitors oseltamivir (Tamiflu; Roche) and zanamivir (Relenza; GlaxoSmithKline). This article reviews agents that have been shown to have activity against influenza A viruses and discusses their therapeutic potential, and also describes emerging strategies for targeting these viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Strategies for mitigating an influenza pandemic
Ferguson, N. M., Cummings, D. A. T., Fraser, C., Cajka, J. C., Cooley, P. C., & Burke, D. S. (2006) · Nature · doi:10.1038/nature04795 · Cited by 2,187
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Strategies for containing an emerging influenza pandemic in Southeast Asia
Ferguson, N. M., Cummings, D. A. T., Cauchemez, S., Fraser, C., Riley, S., Meeyai, A., Iamsirithaworn, S., & Burke, D. S. (2005) · Nature · doi:10.1038/nature04017 · Cited by 1,816
1918 Influenza: the Mother of All Pandemics
Taubenberger, J. K., & Morens, D. M. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.050979 · Cited by 1,686
1918 Influenza: the Mother of All Pandemics
Taubenberger, J. K., & Morens, D. M. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1209.05-0979 · Cited by 1,590
Influenza virus receptors in the human airway
Shinya, K., Ebina, M., Yamada, S., Ono, M., Kasai, N., & Kawaoka, Y. (2006) · Nature · doi:10.1038/440435a · Cited by 1,398
Avian Influenza A (H5N1) Infection in Humans
(2005) · New England Journal of Medicine · doi:10.1056/nejmra052211 · Cited by 1,285
Influenza Pandemics of the 20th Century
Kilbourne, E. D. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.051254 · Cited by 1,224
Cited by
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Self-citationVentura, S. P. M., e Silva, F. A., Quental, M. V., Mondal, D., Freire, M. G., & Coutinho, J. A. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00550 · Cited by 1,024
Human host factors required for influenza virus replication
König, R., Stertz, S., Zhou, Y., Inoue, A., Hoffmann, H. H., Bhattacharyya, S., Alamares, J. G., Tscherne, D. M., Ortigoza, M. B., Liang, Y., et al. (2010) · Nature · doi:10.1038/nature08699 · Cited by 813
Synthesis and medical applications of oligosaccharides
Seeberger, P. H., & Werz, D. B. (2007) · Nature · doi:10.1038/nature05819 · Cited by 755
Structural basis for the function and inhibition of an influenza virus proton channel
Stouffer, A. L., Acharya, R., Salom, D., Levine, A. S., Di Costanzo, L., Soto, C. S., Tereshko, V., Nanda, V., Stayrook, S., & DeGrado, W. F. (2008) · Nature · doi:10.1038/nature06528 · Cited by 636
The structural basis for cap binding by influenza virus polymerase subunit PB2
Guilligay, D., Tarendeau, F., Resa-Infante, P., Coloma, R., Crepin, T., Sehr, P., Lewis, J., Ruigrok, R. W. H., Ortin, J., Hart, D. J., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1421 · Cited by 495
Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol
Kadam, R. U., & Wilson, I. A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617020114 · Cited by 435
The design of drugs for HIV and HCV
Clercq, E. D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2424 · Cited by 430
Evolution of Influenza A Virus by Mutation and Re-Assortment
Shao, W., Li, X., Goraya, M., Wang, S., & Chen, J.-L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081650 · Cited by 427
Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus
Manicassamy, B., Manicassamy, S., Belicha-Villanueva, A., Pisanelli, G., Pulendran, B., & García-Sastre, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914994107 · Cited by 423
Ionic liquid solutions as extractive solvents for value-added compounds from biomass
Passos, H., Freire, M. G., & Coutinho, J. A. P. (2014) · Green Chem. · doi:10.1039/c4gc00236a · Cited by 415
Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion
Russell, R. J., Kerry, P. S., Stevens, D. J., Steinhauer, D. A., Martin, S. R., Gamblin, S. J., & Skehel, J. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807142105 · Cited by 314
The many faces of the adamantyl group in drug design
Liu, J., Obando, D., Liao, V., Lifa, T., & Codd, R. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.047 · Cited by 309
Klein, S. L. (2012) · BioEssays · doi:10.1002/bies.201200099 · Cited by 284
Leneva, I. A., Russell, R. J., Boriskin, Y. S., & Hay, A. J. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2008.10.009 · Cited by 297
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
Short, K. R., Kedzierska, K., & van de Sandt, C. E. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00343 · Cited by 278
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
Tompa, D. R., Immanuel, A., Srikanth, S., & Kadhirvel, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.076 · Cited by 257
Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold?
Hayden, F. (2009) · Clinical Infectious Diseases · doi:10.1086/591851 · Cited by 256
Potent peptidic fusion inhibitors of influenza virus
Kadam, R. U., Juraszek, J., Brandenburg, B., Buyck, C., Schepens, W. B. G., Kesteleyn, B., Stoops, B., Vreeken, R. J., Vermond, J., Goutier, W., et al. (2017) · Science · doi:10.1126/science.aan0516 · Cited by 165
Discovery of a new class of antiviral compounds: camphor imine derivatives
Sokolova, A. S., Yarovaya, O. I., Shernyukov, A. V., Gatilov, Y. V., Razumova, Y. V., Zarubaev, V. V., Tretiak, T. S., Pokrovsky, A. G., Kiselev, O. I., & Salakhutdinov, N. F. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.010 · Cited by 101
Metadata
- Authors
- De Clercq, E.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-12-01
- Volume
- 5
- Issue
- 12
- Pages
- 1015-1025
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2128924487
- Cited by
- 668
- References
- 92
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.